• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2009     NIHR Health Technology Assessment programme Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2008     HAYES, Inc. ViziLite Plus with TBlue (Zila Inc.) as an adjunct to conventional oral mucosal screening for high-risk patients
2007     Adelaide Health Technology Assessment (AHTA) VNS therapy system for the treatment of depression
2005     Adelaide Health Technology Assessment (AHTA) VNS Therapy(TM) System for the treatment of chronic or recurrent treatment-resistant depression in adults
2012     Malaysian Health Technology Assessment (MaHTAS) VNUS® Radiofrequency Ablation (RFA) for varicose vein
2014     HAYES, Inc. Vocal fold steroid injection for treatment of dysphonia
2004     Adelaide Health Technology Assessment (AHTA) Vocera (R) wireless communication
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Voice controlled arthroscopic pump
2016     NIHR Horizon Scanning Centre (NIHR HSC) Voke 0.45mg inhaler for smoking cessation – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Volanesorsen - familial chylomicronemia syndrome – first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2024     Scottish Health Technologies Group (SHTG) Volatile capture technologies
2005     The Swedish Council on Health Technology Assessment (SBU) Volume and quality - a preliminary study
2019     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Volume-outcome relationships: pancreaticoduodenectomy (Whipple procedure). Final report
2014     HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2011     HAYES, Inc. von Willebrand Factor (VWF) gene testing for von Willebrand Disease (VWD)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2020     Agency for Care Effectiveness (ACE) Vonoprazan for treating helicobacter pylori infection
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for acute coronary syndrome
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Voriconazole
2008     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2013     HAYES, Inc. VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2022     Penn Medicine Center for Evidence-based Practice (CEP) VTE chemoprophylaxis for patients undergoing elective spinal surgery
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2006     VA Technology Assessment Program (VATAP) Wait times for primary hip and knee replacement surgery
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Ward rounds - a health technology assessment focused on production of knowledge
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Warm-up therapy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Warming of amniofluid: safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2013     Malaysian Health Technology Assessment (MaHTAS) Water birth
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Water jet systems for surgical dissection and resection
2002     HAYES, Inc. Water-induced thermotherapy (WIT) for benign prostatic hyperplasia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Wavefront analysis in refractive surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines
2009     Adelaide Health Technology Assessment (AHTA) Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2022     Austrian Institute for Health Technology Assessment (AIHTA) Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     European Network for Health Technology Assessment (EUnetHTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2022     Health Technology Wales (HTW) Wearable cardioverter-defibrillators for people at risk of cardiac death
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) WEBLING project: full text web indexes that have been linguistically enhanced and supplemented by services to cross the language barrier (internal report). In cooperation with EU ESPRIT program. IPE-01/i (Internal Report)
2010     Quality Improvement Scotland (NHS QIS ) Weight management programmes for adults
2008     Penn Medicine Center for Evidence-based Practice (CEP) Weight-based dosing nomograms for unfractionated heparin
2010     NIHR Health Technology Assessment programme Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project
2005     NIHR Health Technology Assessment programme Wessex Epidural Steroids Trial (WEST), primary research
2013     Scottish Health Technologies Group (SHTG) What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2002     New Zealand Health Technology Assessment (NZHTA) What are the characteristics of repeating vs. non-repeating suicidal presenters to Emergency services? Evidence Tables
2006     NIHR Health Technology Assessment programme What are the clinical outcome and cost-effectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET)
2015     NIHR Health Services and Delivery Research programme What are the determinants of variations in emergency readmission rates and one-year mortality in patients hospitalized with heart failure or chronic obstructive pulmonary disease?
2002     New Zealand Health Technology Assessment (NZHTA) What are the presenting complaints that should alert clinicians in emergency departments and tertiary mental health settings to the possibility of suicidal ideation/threat/attempts? Evidence Tables
2015     Belgian Health Care Knowledge Centre (KCE) What are the recommended clinical assessment and screening tests during pregnancy?
2009     Health Services Assessment Collaboration (HSAC) What assessment tools are used both in New Zealand and in other countries for grading of evidence?
2017     NIHR Health Technology Assessment programme What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
2002     New Zealand Health Technology Assessment (NZHTA) What clinical features best determine insulin resistance? Evidence Tables
2009     Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2006     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) What effects has the cataract surgery on the development and progression of age-related macular degeneration (AMD)?
2002     New Zealand Health Technology Assessment (NZHTA) What evidence exists about the safety of physical restraint when used by law enforcement and medical staff to control individuals with acute behavioural disturbance?
2002     New Zealand Health Technology Assessment (NZHTA) What evidence is there about the use of seclusion or containment for patients presenting with suicidal behaviours at emergency departments, tertiary mental health services or inpatient units? Evidence Tables
2014     NIHR Health Services and Delivery Research programme What evidence is there for a relationship between organisational features and patient outcomes in congenital heart disease services? A rapid review
2015     NIHR Health Services and Delivery Research programme What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review
2023     NIHR Health Services and Delivery Research programme What factors are associated with informal carers’ psychological morbidity during end-of-life home care? A systematic review and thematic synthesis of observational quantitative studies
2002     New Zealand Health Technology Assessment (NZHTA) What factors determine an inpatient admission as opposed to outpatient referral from emergency services? Evidence Tables
2023     NIHR Health Services and Delivery Research programme What happens after an NHS Health Check? A survey and realist review
2012     Scottish Health Technologies Group (SHTG) What implications does the organisation of vascular services have for rates of amputation?
2018     NIHR Health Technology Assessment programme What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis
2004     NIHR Health Technology Assessment programme What is the best imaging strategy for acute stroke?
2013     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2012     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of microprocessor-controlled artificial knees compared with non-microprocessor-controlled alternatives?
2012     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of temporal artery thermometers compared with infrared in-ear thermometers for temperature measurement in routine clinical practice?
2011     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of the ThinPrep imager® (HologicTM, Inc) for assisted cervical cytology compared with manual reading of liquid based cytology slides?
2014     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of treatment with renal denervation for patients with resistant hypertension?
2015     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
2014     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2012     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
2013     Scottish Health Technologies Group (SHTG) What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2015     NIHR Public Health Research (PHR) programme What is the effect of reduced street lighting on crime and road traffic injuries at night? A mixed-methods study
2000     Centre for Clinical Effectiveness (CCE) What is the effectiveness of a dressing moistened with sodium hypochlorite (Dakins) solution compared to other dressings in improving wound healing?